25 related articles for article (PubMed ID: 1477938)
1. Co-alteration of Myc and RTK-RAS pathways defines a liver-metastatic propensity and immune-cold subgroup of pancreatic adenocarcinoma.
Zhang Y; Zu Z; Xu H; Weng S; Ren Y; Cheng Q; Luo P; Zhang J; Liu Z; Han X
Genes Dis; 2024 May; 11(3):100993. PubMed ID: 38274372
[No Abstract] [Full Text] [Related]
2. [Point mutation at codon 12 of c-Ki-ras oncogene in human pancreatic neoplasms and normal human pancreas tissue].
Cui Q; Wang Z; Chen J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun; 16(3):201-5. PubMed ID: 7805165
[TBL] [Abstract][Full Text] [Related]
3. [Expression of c-myc and c-ki-ras oncogene in human pancreatic carcinoma].
Li DC
Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):30-2. PubMed ID: 1396043
[TBL] [Abstract][Full Text] [Related]
4. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.
Urban T; Ricci S; Grange JD; Lacave R; Boudghene F; Breittmayer F; Languille O; Roland J; Bernaudin JF
J Natl Cancer Inst; 1993 Dec; 85(24):2008-12. PubMed ID: 7902444
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
6. [Oncogene expression and point mutation in human pancreatic adenocarcinomas].
Li DC; Liu TH
Zhonghua Bing Li Xue Za Zhi; 1992 Jun; 21(3):152-5. PubMed ID: 1477938
[TBL] [Abstract][Full Text] [Related]
7. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
[TBL] [Abstract][Full Text] [Related]
8. Mutational activation of the c-K-ras gene in human pancreatic carcinoma.
Shibata D; Capella G; Perucho M
Baillieres Clin Gastroenterol; 1990 Mar; 4(1):151-69. PubMed ID: 1976394
[TBL] [Abstract][Full Text] [Related]
9. K-ras mutation and pancreatic adenocarcinoma.
Caldas C; Kern SE
Int J Pancreatol; 1995 Aug; 18(1):1-6. PubMed ID: 7594765
[No Abstract] [Full Text] [Related]
10. Growth factors and oncogenes in pancreatic cancer.
Lemoine NR; Hall PA
Baillieres Clin Gastroenterol; 1990 Dec; 4(4):815-32. PubMed ID: 1964102
[TBL] [Abstract][Full Text] [Related]
11. [Genetic alterations in human pancreatic cancer].
Horii A
Nihon Shokakibyo Gakkai Zasshi; 2000 Jul; 97(7):888-94. PubMed ID: 10934871
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
